Nova Patents
PL2654864T3

System for drug delivery

Abstract

This record has no abstract on file.

Term

5.2 yearsto projected expiry

Projected expiry 22 December 2031, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

26 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims10

Priority claims
DocumentOfficeKindDate
201061425962United States of AmericaP
201061425962United States of AmericaP
11815728European Patent Office (EPO)A
2011050071IsraelW
2011050071IsraelW
118157288–––
201061425962P–––
EP20110815728–––
US201061425962P–––
WO2011IL50071–––

Members26

Family members, oldest first
DocumentOfficeKind
CA2822738A1CanadaA1
CA3114582A1CanadaA1
WO2012085919A2World Intellectual Property Organization (WIPO)A2
WO2012085919A3World Intellectual Property Organization (WIPO)A3
US2013276799A1United States of AmericaA1
EP2654864A2European Patent Office (EPO)A2
US9775379B2United States of AmericaB2
US2017360089A1United States of AmericaA1
IL227102AIsraelA
IL227102BIsraelB
IL262376AIsraelA
IL262376D0IsraelD0
EP2654864B1European Patent Office (EPO)B1
CA2822738CCanadaC
US11033488B2United States of AmericaB2
EP3834869A1European Patent Office (EPO)A1
PL2654864T3This recordPolandT3
ES2842407T3SpainT3
US11071712B2United States of AmericaB2
US2021236414A1United States of AmericaA1
IL262376BIsraelB
IL298116AIsraelA
IL262376B2IsraelB2
US11766399B2United States of AmericaB2
US2023390186A1United States of AmericaA1
EP3834869B1European Patent Office (EPO)B1